We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Long-term IOP reduction closely ...
A new report suggests corticosteroids likely are not a panacea for ocular surface disease, a potential adverse effect of trabeculectomy. Patients who took steroid eye drops before trabeculectomy for ...
Please provide your email address to receive an email when new articles are posted on . CBT-004 demonstrated rapid onset of improvement in conjunctival hyperemia. Cloudbreak Pharma is advancing ...
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced topline results from its two Phase 3 clinical trials, STRIDE 1 and STRIDE 2 (STRIDE - Short Term Relief In ...
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic products based on its proprietary mucus-penetrating particle (MPP) technology, today announced ...
This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, ...
Detailed price information for Bausch Lomb Corporation (BLCO-T) from The Globe and Mail including charting and trades.
Conjunctival hyperemia in the right eye (Panel A) and left eye (Panel B) 8 days after the onset of systemic symptoms is shown. Also shown are keratic precipitates and grade 2+ inflammatory cells (on a ...
A retrospective review was conducted on patients with the immunopathological diagnosis of pemphigus examined between 1 January 2000 and 1 April 2010. Uncorrected distance visual acuity (UDVA), best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results